Watch more videos on our ROKStudios hub page.
Life sciences manufacturing is undergoing a profound transformation, driven by the need for agility, compliance, and innovation. As therapies become more personalized and regulatory expectations intensify, manufacturers are turning to advanced Manufacturing Execution Systems (MES) to bridge the gap between operational efficiency and quality assurance.
Paul Murray, Managing Director of Industry X and Manufacturing Supply Chain Systems at Accenture, joined us in the ROKStudios to explore how digital execution platforms are reshaping production environments, enabling real-time data visibility, and supporting sustainable, patient-centric supply chains.